MRVI in the 13F filings
Maravai Lifesciences HLDGS I · CUSIP 56600D107
- Quarter end
- 30 Sep 2023
- the date the book describes
- Filed
- 14 Nov 2023
- latest of these filings; the earliest 8 Nov 2023
- Managers listing it
- 6
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q2 2023 and Q3 2023; 5 listed it in both
- Shares listed
- 15,492,173
- combined, among listed positions
- Reported value
- $155m
- combined, at the quarter end
Managers listing MRVI in Q3 2023
6 of 6 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| MFS Investment Management | 8,153,480 | $82m | under 0.1% | Trimmed | -3,000,776 | 8 Nov 2023 (the filing on sec.gov) |
| Renaissance Technologies LLC | 2,659,689 | $27m | under 0.1% | Added | +218,514 | 14 Nov 2023 (the filing on sec.gov) |
| Holocene Advisors LP | 2,151,656 | $22m | 0.09% | New | new | 14 Nov 2023 (the filing on sec.gov) |
| Two Sigma Advisers LP | 1,733,500 | $17m | under 0.1% | Trimmed | -748,100 | 14 Nov 2023 (the filing on sec.gov) |
| Hudson Bay Capital Management LP | 659,397 | $6.6m | 0.05% | Added | +416,876 | 14 Nov 2023 (the filing on sec.gov) |
| PDT Partners LLC | 134,451 | $1.3m | 0.17% | Added | +35,484 | 14 Nov 2023 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Holocene Advisors LPnew position · 2,151,656 shares now+2,151,656
- Hudson Bay Capital Management LPexisting position · 659,397 shares now+416,876
- Renaissance Technologies LLCexisting position · 2,659,689 shares now+218,514
- PDT Partners LLCexisting position · 134,451 shares now+35,484
Reductions
- MFS Investment Managementexisting position · 8,153,480 shares now-3,000,776
- Two Sigma Advisers LPexisting position · 1,733,500 shares now-748,100
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2020 | 11 | $410m | n.a. | n.a. |
| Q1 2021 | 4 | $230m | n.a. | n.a. |
| Q2 2021 | 8 | $819m | n.a. | n.a. |
| Q3 2021 | 10 | $1.4bn | n.a. | n.a. |
| Q4 2021 | 6 | $900m | n.a. | n.a. |
| Q1 2022 | 4 | $342m | n.a. | n.a. |
| Q2 2022 | 4 | $447m | n.a. | n.a. |
| Q3 2022 | 7 | $527m | n.a. | n.a. |
| Q4 2022 | 8 | $360m | n.a. | n.a. |
| Q1 2023 | 8 | $291m | n.a. | n.a. |
| Q2 2023 | 7 | $234m | n.a. | n.a. |
| Q3 2023 | 6 | $155m | n.a. | n.a. |
| Q4 2023 | 3 | $73m | 2 | 1 |
| Q1 2024 | 5 | $110m | 2 | 3 |
| Q2 2024 | 6 | $91m | 4 | 2 |
| Q3 2024 | 1 | $34m | 1 | 1 |
| Q4 2024 | 1 | $251k | n.a. | n.a. |
| Q3 2025 | 1 | $1.3m | 1 | 0 |
| Q4 2025 | 1 | $5.8m | 13 | 9 |
| Q1 2026 | 1 | $7.1m | 13 | 7 |
| Q2 2026 | 2 | $24m | 19 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MRVI and LLY →MRVI and JNJ →MRVI and VRTX →Choose a stock to compare with MRVI →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MRVI, latest filings →Back to the 13F Explorer →